Awarded contractNeg Wo CallSuppliesSpain
suministro del medicamento REBLOZYL (principio activo LUSPATERCEPT 25 MG vial polvo subcutanea, LUSPATERCEPT 75 MG vial polvo subcutanea) Y ZEPOSIA (principio activo OZANIMOD 0,92 MG capsula oral), con destino Servicio de Farmacia del Hospital Universitario Nuestra Señora de Candelaria
1 supplier awarded•1 lot awarded•€233,840 awarded
Buyer: Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria / Santa Cruz de Tenerife, Spain
Published Jun 12, 2024Awarded Jun 09, 2024
Various medicinal products
Awarded value
€233.8K
Estimated value
€233.8K
Awarded at 100% of estimated value
Award date
Jun 09, 2024
Winners
1
Lots awarded
1
Winners
Bristol Myers Squibb. S.A.U.
1 lotMADRID, ESP
€233,840 This contract
10 award notices•13 awarded lots•€82.13M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0000 | Bristol Myers Squibb. S.A.U. | €233,840 | Various medicinal products (33690000) |